Skip to content

B Cell Childhood Acute Lymphoblastic Leukemia C0279584

Published: July 22, 2026Updated: August 20, 2026

The most common childhood cancer. Modern treatment leads to excellent survival rates. Treated with multi-drug chemotherapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
critical
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

Fatigue

(hematologic)

Pallor

(hematologic)

Fever

(immune)

Severe bone pain

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Image-guided procedure with follow-up care

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
2

Multi-Agent Chemotherapy Protocol

Intensive combination chemotherapy regimen typically spanning 2-3 years, combining multiple anticancer drugs to eliminate leukemic cells from the blood and bone marrow. Treatment phases include induction, consolidation, interim maintenance, delayed intensification, and maintenance therapy.

medication

Additional treatment options

Hematopoietic Stem Cell Transplantation

High-dose chemotherapy followed by infusion of healthy stem cells to restore bone marrow function, typically considered when leukemia recurs or fails to respond to initial chemotherapy. The procedure requires a compatible donor and extensive pre-transplant evaluation.

procedure

Targeted Biologic Therapy

Monoclonal antibodies or targeted agents that specifically attack leukemic cells while sparing normal cells. These newer therapies may be used in combination with chemotherapy or for relapsed disease.

medication

Central Nervous System Prophylaxis

Preventive treatment to stop leukemic spread to the brain and spinal cord, including intrathecal chemotherapy injections directly into the cerebrospinal fluid. May be combined with cranial radiation in high-risk cases.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is B Cell Childhood Acute Lymphoblastic Leukemia C0279584?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hunger SP, Mullighan CG. Acute Lymphoblastic Leukemia in Children. N Engl J Med. 2015;373(16):1541-1552.

guideline2015
2

Pui CH, Yang JJ, Hunger SP, et al. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration. J Clin Oncol. 2015;33(27):2938-2948.

review2015
3

Taur PDB, Arora M, Seth T. Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis. Biol Blood Marrow Transplant. 2020;26(5):937-947.

meta_analysis2020
4

Maude SL, Laetsch TW, Buechner J, et al. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia. N Engl J Med. 2018;378(5):439-448.

clinical_trial2018

Medication Comparisons

Compare medications used to treat B Cell Childhood Acute Lymphoblastic Leukemia C0279584. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy